Kerasal

Kerasal is a leading consumer healthcare brand specializing in over-the-counter (OTC) foot and nail care solutions. Originally developed and marketed by Moberg Pharma, the brand was acquired by Advantice Health (backed by RoundTable Healthcare Partners) in 2019. Kerasal's product portfolio focuses on clinically proven topical treatments for conditions such as fungal nail damage, athlete's foot, and extreme skin dryness. Their flagship products, including Kerasal Fungal Nail Renewal and Kerasal Intensive Foot Repair, utilize specialized formulations to improve the appearance and health of nails and skin. The company maintains a strong retail presence across North America and continues to innovate within the podiatric and dermatological consumer segments.